S. Garcia

J. Mazières, C. Mascaux, F. Barlesi, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma

F. Barlesi, L. Ouafik, K. Mabrouk, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Comparison of thyroid peroxidase expression with cellular proliferation in thyroid follicular tumors.

J. Henry, S. Garcia, C. De Micco, 1998, Thyroid : official journal of the American Thyroid Association.

Fine-needle aspiration of thyroid follicular neoplasm: diagnostic use of thyroid peroxidase immunocytochemistry with monoclonal antibody 47.

V. Vasko, J. Henry, S. Garcia, 1994, Surgery.

Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression.

P. Bonnier, Jean P Dales, Stephane Garcia, 2004, Human pathology.

The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers

P. Bonnier, J. Dales, S. Garcia, 2003 .

Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10‐year follow‐up by automated and quantitative immunocytochemical assays

P. Bonnier, L. Andrac, C. Charpin, 1998, The Journal of pathology.

Pure spindle cell follicular carcinoma of the thyroid.

V. Secq, S. Giusiano-Courcambeck, S. Garcia, 2008, Thyroid : official journal of the American Thyroid Association.

VCAM (IGSF) adhesion molecule expression in breast carcinomas detected by automated and quantitative immunocytochemical assays.

L. Andrac, C. Charpin, C Charpin, 1998, Human pathology.

VLA2 integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry.

L. Andrac, C. Charpin, S. Garcia, 1998, British Journal of Cancer.

E‐cadherin quantititive immunocytochemical assays in breast carcinomas

C. Bouvier, L. Andrac, C. Charpin, 1997, The Journal of pathology.

c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.

P. Bonnier, L. Andrac, C. Charpin, 1997, British Journal of Cancer.

[Retroperitoneal ectopic pregnancy: report of a case].

C. Charpin, J. Hardwigsen, S. Garcia, 1998, Annales de pathologie.

c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays

D. Birnbaum, P. Bonnier, E. Charafe-Jauffret, 2007, British Journal of Cancer.

Tie2/Tek expression in breast carcinoma: correlations of immunohistochemical assays and long-term follow-up in a series of 909 patients.

P. Bonnier, F. Duffaud, C. Charpin, 2003, International journal of oncology.

Validation of an immunohistochemical signature predictive of 8‐year outcome for patients with breast carcinoma

D. Birnbaum, J. Iovanna, P. Bonnier, 2012, International journal of cancer.

Immunohistochemical profiling of node negative breast carcinomas allows prediction of metastatic risk.

D. Birnbaum, J. Iovanna, P. Bonnier, 2010, International journal of oncology.

Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis.

P. Bonnier, E. Charafe-Jauffret, J. Jacquemier, 2007, International journal of oncology.

A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort

S. Truant, E. Assenat, G. Piessen, 2018, BMC Cancer.

Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma.

P. Bonnier, Claude Allasia, Pascal Bonnier, 2005, International journal of oncology.

[Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].

P. Bonnier, F. Duffaud, L. Andrac, 2003, Annales de pathologie.

Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions

S. Hilsenbeck, K. Podsypanina, C. Nagi, 2018, Breast Cancer Research.

Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas.

C. Bouvier, L. Andrac, C. Charpin, 1997, Human pathology.

Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas.

P. Bonnier, V. Secq, L. Andrac, 2009, International journal of oncology.

Immunoexpression of E-cadherin and beta-catenin correlates to survival of patients with hepatocellular carcinomas.

Y. L. Le Treut, L. Andrac, C. Charpin, 1998, International journal of oncology.

Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas

C. Bouvier, L. Andrac, C. Charpin, 1997, International journal of cancer.

Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer : a retrospective study in a series of 745 patients.

P. Bonnier, M. Silvy, C. Picard, 2005 .

Abstract 5529: PD-L1 and CD8 IHC dual assessment in NSCLC using the Halioseek® assay: A multicentric study

J. Galon, J. Adam, Y. Boumber, 2018, Clinical Research (Excluding Clinical Trials).

Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC).

J. Mazières, C. Mascaux, F. Barlesi, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.